The active substance in Tolterodinetartraat Mylan is tolterodine tartrate. Tolterodine belongs to a class of medicinal products called antimuscarinics.
Tolterodinetartraat Mylan is used in adults and the elderly for the treatment of the symptoms of overactive bladder syndrome. If you have overactive bladder syndrome, you may find that you are unable to control urination or you need to rush to the toilet with no advance warning and/or go to the toilet frequently.
|Wanneer mag u dit middel niet gebruiken of moet u er extra voorzichtig mee zijn?|
|Hoe gebruikt u dit middel?|
|Hoe bewaart u dit middel?|
Do not take Tolterodinetartraat Mylan
- if you are allergic to tolterodine or any of the other ingredients of this medicine (listed in section 6)
- if you are unable to pass urine from the bladder (urinary retention)
- if you have high pressure in the eyes with loss of eyesight that is not being adequately treated (uncontrolled narrow-angle glaucoma)
- if you suffer from excessive weakness of the muscles (myasthenia gravis)
- if you suffer from severe ulceration and inflammation of the colon (severe ulcerative colitis)
- if you suffer from acute widening of the colon (toxic megacolon).
Warnings and precautions
Talk to your doctor or pharmacist before taking Tolterodinetartraat Mylan if you:
- have difficulties in passing urine and/or a poor stream of urine
- have a gastro-intestinal disease that affects the passage and/or digestion of food
- suffer from kidney problems (renal insufficiency)
- have a liver condition
- suffer from neuronal disorders that affect your blood pressure, bowel or sexual function (any neuropathy of the autonomic nervous system)
- have a hiatal hernia (a hernia in the upper part of stomach)
- ever experience decreased bowel movements or suffer from severe constipation (decreased gastro-intestinal motility)
- have a heart condition such as:
- an abnormal heart tracing (ECG)
- a slow heart rate (bradycardia)
- have a pre-existing heart disease such as cardiomyopathy (weak heart muscle), myocardial ischaemia (reduced blood flow to the heart), arrhythmia (irregular heartbeat) and heart failure
- have abnormally low levels of potassium (hypokalaemia), calcium (hypocalcaemia) or magnesium (hypomagnesaemia) in your blood.
Talk to your doctor or pharmacist before starting your treatment with Tolterodinetartraat Mylan if you think any of these might apply to you.
Other medicines and Tolterodinetartraat Mylan
Tolterodine tartate, the active substance of Tolterodinetartraat Mylan, may interact with other medicinal products.
It is not recommended to take this medicine in combination with:
- some antibiotics (e.g. erythromycin, clarithromycin)
- medicinal products used for the treatment of fungal infections (e.g. ketoconazole, itraconazole)
- medicinal products used for the treatment of HIV.
Tolterodinetartraat Mylan should be used with caution when taken in combination with:
- medicines that affect the passage of food (e.g. metoclopramide and cisapride);
- medicines for the treatment of irregular heartbeat (e.g. amiodarone, sotalol, quinidine, procainamide);
- other medicines with a similar mode of action to Tolterodinetartraat Mylan (antimuscarinic properties) or medicines with an opposite mode of action to Tolterodinetartraat Mylan (cholinergic properties). Ask your doctor if you are unsure.
Tell your doctor or pharmacist if you are taking or have recently taken any other medicines.
Taking Tolterodinetartraat Mylan with food and drink
Tolterodinetartraat Mylan can be taken before, after or during a meal.
Pregnancy and breast-feeding
You should not take Tolterodinetartraat Mylan when you are pregnant. Tell your doctor immediately if you are pregnant, think you are pregnant or are planning to have a baby.
Tell your doctor if you are breast-feeding or about to start breast-feeding. Tolterodinetartraat Mylan is not recommended for mothers who are breast-feeding.
Ask your doctor or pharmacist for advice before taking this medicine.
Driving and using machines
Do not drive or operate machinery whilst taking Tolterodinetartraat Mylan as it may make you feel dizzy, tired or affect your sight.
Tolterodinetartraat Mylan contains sucrose (a type of sugar)
If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicine.
Always take this medicine exactly as your doctor has told you. Check with your doctor or pharmacist if you are not sure.
The recommended dose is one 4 mg prolonged-release capsule daily. For patients who have a kidney or a liver condition or troublesome side effects, your doctor may reduce your dose to one 2 mg prolonged-release capsule daily.
Use in Children
Tolterodinetartraat Mylan is not recommended for children.
The prolonged-release capsules should be swallowed whole with a glass of water with or without food. Do not chew the capsules.
Duration of treatment
Your doctor will tell you how long your treatment with Tolterodinetartraat Mylan will last. Your bladder will need some time to adapt. Do not stop treatment early because you do not see an immediate effect. Finish the course of prolonged-release capsules prescribed by your doctor. If you have not noticed any effect by then, talk to your doctor.
The benefit of the treatment should be re-evaluated after 2 or 3 months.
If you take more Tolterodinetartraat Mylan than you should
If you or somebody else takes too many prolonged-release capsules, contact your doctor or pharmacist immediately or go to the nearest hospital emergency department.
Signs of overdose to look for are: hallucinations, severe excitation, convulsions, increased heart beat, shortness of breath, difficulty to pass urine or widening of pupils.
If you forget to take Tolterodinetartraat Mylan
If you forget to take a dose at the usual time, take it as soon as you remember unless it is almost time for your next dose. In that case, omit the forgotten dose and follow the normal dose schedule. Do not take a double dose to make up for a forgotten dose.
If you stop taking Tolterodinetartraat Mylan
Do not stop taking this medicine unless your doctor advises you to stop.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
You should see your doctor immediately or go to the hospital emergency department if you experience symptoms of angioedema such as:
- swollen face, tongue, throat
- difficulty to swallow
- hives and difficulty in breathing
You should also seek medical attention if you experience a hypersensitivity reaction (for example itching, rash, hives or difficulty breathing). This occurs uncommonly (occurs in less than 1 in 100 patients).
Tell your doctor immediately or go to the hospital emergency department if you notice any of the following:
- chest pain, difficulty breathing or getting tired easily (even at rest), difficulty breathing at
night, swelling of the legs.
These may be symptoms of heart failure. This occurs uncommonly (occurs in less than 1 in 100 patients).
The following side effects have been observed during treatment with Tolterodinetartraat Mylan with the following frequencies.
Very common side effects (may affect more than 1 in 10 patients)
- dry mouth
Common side effects (may affect up to 1 in 10 patients)
- dizziness, sleepiness, headache
- dry eyes, blurred vision
- difficulty with digestion (dyspepsia), constipation, abdominal pain, excessive amounts of air or gases in the stomach or the intestine
- painful or difficult urination
- extra fluid in the body causing swelling (e.g. in the ankles)
Uncommon side effects (may affect up to 1 in 100 patients)
- allergic reactions
- sensation of pins and needles in the fingers and toes
- feeling of spinning, dizziness (vertigo)
- palpitations, heart failure, irregular heartbeat
- inability to empty the bladder
- chest pain
- memory impairment
Additional reactions reported include severe allergic reactions, confusion, hallucinations, increased heart rate, flushed skin, heart burn, vomiting, angioedema, dry skin, and disorientation. There have also been reports of worsening symptoms of dementia in patients being treated for dementia.
If you get any side effects, talk to your doctor or pharmacist. This includes any side effects not listed in this leaflet.
Keep out of the sight and reach of children.
Do not take this medicine after the expiry date, which is stated on the carton. The expiry date refers to the last day of that month.
Store below 30°C.
Do not throw away any medicine via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.
What Tolterodinetartraat Mylan contains
The active substance is tolterodine tartrate. Each prolonged–release capsule contains 2 mg tolterodine tartrate which is equivalent to 1.37 mg of tolterodine.
The other ingredients are sugar spheres (sucrose and maize starch), ethylcellulose (E462), hypromellose (E464) and talc (E553b). The capsule shell contains indigo carmine (E132), yellow iron oxide (E172), titanium dioxide (E171) and gelatin (E441). The printing ink contains shellac (E904), propylene glycol (E1520), black iron oxide (E172) and potassium hydroxide.
What Tolterodinetartraat Mylan looks like and contents of the pack
Tolterodinetartraat Mylan 2 mg prolonged-release capsules are green opaque hard-shell gelatin capsules filled with white to off-white beads. The capsules are marked with MYLAN over 3402 in black ink on both parts of the capsule.
Your medicine is packed in perforated unit dose containing 14x1, 28x1 and 30x1 prolonged-release capsules. Not all pack sizes may be marketed.
Dit middel is ingeschreven in het register onder:
Tolterodinetartraat Mylan 2 mg, capsules met verlengde afgifte, hard: RVG 108824
Houder van de vergunning voor het in de handel brengen en fabrikant
Houder van de vergunning
3752 LB Bunschoten Nederland
McDermott Laboratories Ltd. t/a Gerard Laboratories, 35/36 Baldoyle Industrial Estate, Grange Road, Dublin 13, Ierland.
Generics [UK] Limited, Station Close, Potters Bar, Hertfordshire, EN6 1TL, Verenigd Koninkrijk.
This medicinal product is authorised in the Member States of the EEA under the following names:
|Italy||Tolterodina Mylan Generics, 2mg, prolonged release capsules|
|The Netherlands||Tolterodinetartraat Mylan 2 mg, capsules met verlengde afgifte, hard|
Deze bijsluiter is voor het laatst goedgekeurd in april 2012.